ArticleBMC surgery2026
Percutaneous laparoscopic harvest and trans-vaginal implantation of autologous rectus fascia in the treatment of severe anterior vaginal prolapse.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo observe the efficacy of percutaneous laparoscopic harvest and trans-vaginal implantation of autologous rectus fascia (ARF) in the treatment of severe anterior vaginal prolapse (SAP). MATERIALS AND
methodsAll women who underwent percutaneous laparoscopic harvest and trans-vaginal Implantation of ARF to treat SAP between December 2022 to December 2023 at a single center. Major measurements include operation time, blood loss, postoperative hospital stay, Pelvic Floor Distress Inventory-20 (PFDI-20), patient satisfaction, Patient Global Impression of Improvement (PGI-I), Pelvic Organ Prolapse Quantification (POP-Q). All patients were followed up at 3 months, 1 year and 2 years after the surgery.
results7 patients underwent pelvic floor repairing surgery using the described technique with an average age of 63.6 years, BMI 24.0 kg/m
conclusionHarvesting ARF by percutaneous laparoscopy is feasible, and trans-vaginal implantation of ARF to treat SAP has good effects, high safety, and high postoperative satisfaction. More data and longer-term follow-up are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.